Martin LW, Correa AM, Dolormente M, Francisco R, Martin F, Sarabia AJ, Hong WK, Smythe RW, Putnam JB, Hofstetter WL , Rice DC, Vaporciyan AA, Swisher SG, Walsh GL, Roth JA
[21] In a 2003 meta-analysis of 21 clinical trials, a total of 1,204 adults with mild cognitive impairment took supplements containing 1.5 g to 3.0 g/day acetyl L-carnitine (ALCAR) or placebo for 3 to 12 months
Why study dosing is not a personal dose A study dose answers a research question
The findings of the meta-analysis were also summarized into forest plots to portray them visually
Risks include: Unknown purity contaminants, degradation products, or incorrect concentrations Mislabeling actual peptide content may differ from stated amount Bacterial contamination improper manufacturing or storage If you choose to use MT-2, sourcing from vendors with third-party certificates of analysis (COA) is essential
Love the feeling it gives!* Was this helpful